Medicare Rx “Tripartisan” Group Backing Away From $400 Bil. Cost
Executive Summary
Proposals for a Medicare prescription drug benefit should increase the level of beneficiary cost sharing to fit within the available financial resources, Senate Finance Committee health policy director Linda Fishman told an Alliance for Health Reform forum Dec. 19 in Washington, D.C